tiprankstipranks
Sellas Life Sciences Group (SLS)
NASDAQ:SLS
US Market
SLS
SELLAS Life Sciences Group
RESEARCH TOOLSreports
Want to see SLS full AI Analyst Report?

SELLAS Life Sciences Group (SLS) Income Statement

1,397 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q4 2025), SELLAS Life Sciences Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, SELLAS Life Sciences Group's net income was $-7.66M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.00M$ 7.60M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 900.00K$ 7.40M
Operating Expenses
$ 28.27M$ 31.51M$ 37.87M$ 42.85M$ 32.69M
Depreciation and Amortization
$ 0.00$ 31.51M$ 37.87M$ 457.00K$ 1.27M
EBITDA
$ -28.27M$ 632.00K$ 529.00K$ -31.49M$ -18.32M
Operating Income
$ -28.27M$ -31.51M$ -37.87M$ -41.95M$ -25.29M
Other Income/Expenses
$ 1.41M$ 632.00K$ 529.00K$ 649.00K$ 4.36M
Pretax Income
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.94M
Net Income
$ -26.86M$ -30.88M$ -37.34M$ -41.30M$ -20.70M
Per Share Metrics
Basic EPS
$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Diluted EPS
$ -0.25$ -0.50$ -1.34$ -2.13$ -1.34
Weighted Average Shares Outstanding
 109.05M 61.20M 27.78M 19.39M 15.48M
Weighted Average Shares Outstanding (Diluted)
 109.05M 61.20M 27.78M 19.40M 15.48M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History